Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting

Abstract

Deciding when to biopsy a man with non-suspicious DRE findings and tPSA in the 4–10 ng/ml range can be challenging, because two-thirds of such biopsies are typically found to be benign. The Prostate Health Index (phi) exhibits significantly improved diagnostic accuracy for prostate cancer detection when compared to tPSA and %fPSA, however only one published… (More)
DOI: 10.1038/s41391-017-0008-7

5 Figures and Tables

Topics

  • Presentations referencing similar topics